+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Swedish Orphan Biovitrum AB - logo

Sobi is a leading integrated biopharmaceutical company that focuses on developing therapies and treatments for haemophilia, inflammation, genetic and metabolic diseases. Its operations are split into three core areas: Core Products, Partner Products and ReFacto Manufacturing. The organisation spans 24 countries, delivering therapies to patients in 67 countries across the globe. However, Europe accounts for up to 54 per cent of its sales. Sobi is headquartered in Stockholm, Sweden.

From
Gouty Arthritis (Gout) - Pipeline Review, H2 2020 - Product Thumbnail Image

Gouty Arthritis (Gout) - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 139 pages
From
From
From
From
From
From
From
From
From
Interleukin 1 (IL1) - Drugs in Development, 2021 - Product Thumbnail Image

Interleukin 1 (IL1) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
From
Ulcerative Colitis - Pipeline Review, H2 2020 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 779 pages
From
From
From
From
From
From
From
Loading Indicator
adroll